ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES

Detalhes bibliográficos
Autor(a) principal: Balio,Beatriz Gandra
Data de Publicação: 2023
Outros Autores: Giro,Rita, Roriz,Maria
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S2183-59852023000100060
Resumo: ABSTRACT The prevalence of gastrointestinal diseases has increased substantially in the last few years, bringing consequences not only to quality of life, but also to patients’ emotional/psychological wellbeing. Preliminary data from experimental studies suggest that using nutraceuticals as an adjuvant therapy to improve gastrointestinal symptomology may be a relevant and innovative strategy, since first line pharmacological treatments may pose severe adverse effects, drug resistance and lack of patient compliance. This narrative review aimed to explore the potential of four bioactive compounds at improving gastrointestinal symptomatology and disease management. Additionally, the mechanisms of action and dosages underlying the positive effects of these substances in improving quality of life and risk of disease relapse are also explored. According to the evidence found, peppermint oil and probiotics appear to ameliorate irritable bowel syndrome symptomatology, whereas polyphenols such as curcumin suggest a complementary effect in inducing and maintaining clinical remission among ulcerative colitis patients. Evidence regarding ginger’s effect on gastrointestinal symptoms is lacking and demonstrates little to no expression in irritable bowel syndrome nor functional dyspepsia.In conclusion, the consumption of peppermint oil, polyphenols and probiotics may be a viable adjuvant in the management of gastrointestinal diseases, associated symptomology and quality of life. However, further randomized controlled trials are warranted to elucidate on the optimal dose, safety and long-term efficacy of supplementing with these components, and particularly on the potential relevance of ginger supplementation.
id RCAP_60ef3fd10d1809e035770b63e2a1324c
oai_identifier_str oai:scielo:S2183-59852023000100060
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASESClinical nutritionDietary supplementGastroenterologyNutraceuticalsTherapeutic useABSTRACT The prevalence of gastrointestinal diseases has increased substantially in the last few years, bringing consequences not only to quality of life, but also to patients’ emotional/psychological wellbeing. Preliminary data from experimental studies suggest that using nutraceuticals as an adjuvant therapy to improve gastrointestinal symptomology may be a relevant and innovative strategy, since first line pharmacological treatments may pose severe adverse effects, drug resistance and lack of patient compliance. This narrative review aimed to explore the potential of four bioactive compounds at improving gastrointestinal symptomatology and disease management. Additionally, the mechanisms of action and dosages underlying the positive effects of these substances in improving quality of life and risk of disease relapse are also explored. According to the evidence found, peppermint oil and probiotics appear to ameliorate irritable bowel syndrome symptomatology, whereas polyphenols such as curcumin suggest a complementary effect in inducing and maintaining clinical remission among ulcerative colitis patients. Evidence regarding ginger’s effect on gastrointestinal symptoms is lacking and demonstrates little to no expression in irritable bowel syndrome nor functional dyspepsia.In conclusion, the consumption of peppermint oil, polyphenols and probiotics may be a viable adjuvant in the management of gastrointestinal diseases, associated symptomology and quality of life. However, further randomized controlled trials are warranted to elucidate on the optimal dose, safety and long-term efficacy of supplementing with these components, and particularly on the potential relevance of ginger supplementation.Associação Portuguesa de Nutrição2023-03-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2183-59852023000100060Acta Portuguesa de Nutrição n.32 2023reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2183-59852023000100060Balio,Beatriz GandraGiro,RitaRoriz,Mariainfo:eu-repo/semantics/openAccess2024-02-06T17:31:16Zoai:scielo:S2183-59852023000100060Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:34:27.385827Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES
title ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES
spellingShingle ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES
Balio,Beatriz Gandra
Clinical nutrition
Dietary supplement
Gastroenterology
Nutraceuticals
Therapeutic use
title_short ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES
title_full ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES
title_fullStr ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES
title_full_unstemmed ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES
title_sort ADJUVANT NUTRACEUTICALS IN THE MANAGEMENT OF GASTROINTESTINAL DISEASES
author Balio,Beatriz Gandra
author_facet Balio,Beatriz Gandra
Giro,Rita
Roriz,Maria
author_role author
author2 Giro,Rita
Roriz,Maria
author2_role author
author
dc.contributor.author.fl_str_mv Balio,Beatriz Gandra
Giro,Rita
Roriz,Maria
dc.subject.por.fl_str_mv Clinical nutrition
Dietary supplement
Gastroenterology
Nutraceuticals
Therapeutic use
topic Clinical nutrition
Dietary supplement
Gastroenterology
Nutraceuticals
Therapeutic use
description ABSTRACT The prevalence of gastrointestinal diseases has increased substantially in the last few years, bringing consequences not only to quality of life, but also to patients’ emotional/psychological wellbeing. Preliminary data from experimental studies suggest that using nutraceuticals as an adjuvant therapy to improve gastrointestinal symptomology may be a relevant and innovative strategy, since first line pharmacological treatments may pose severe adverse effects, drug resistance and lack of patient compliance. This narrative review aimed to explore the potential of four bioactive compounds at improving gastrointestinal symptomatology and disease management. Additionally, the mechanisms of action and dosages underlying the positive effects of these substances in improving quality of life and risk of disease relapse are also explored. According to the evidence found, peppermint oil and probiotics appear to ameliorate irritable bowel syndrome symptomatology, whereas polyphenols such as curcumin suggest a complementary effect in inducing and maintaining clinical remission among ulcerative colitis patients. Evidence regarding ginger’s effect on gastrointestinal symptoms is lacking and demonstrates little to no expression in irritable bowel syndrome nor functional dyspepsia.In conclusion, the consumption of peppermint oil, polyphenols and probiotics may be a viable adjuvant in the management of gastrointestinal diseases, associated symptomology and quality of life. However, further randomized controlled trials are warranted to elucidate on the optimal dose, safety and long-term efficacy of supplementing with these components, and particularly on the potential relevance of ginger supplementation.
publishDate 2023
dc.date.none.fl_str_mv 2023-03-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S2183-59852023000100060
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S2183-59852023000100060
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S2183-59852023000100060
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Portuguesa de Nutrição
publisher.none.fl_str_mv Associação Portuguesa de Nutrição
dc.source.none.fl_str_mv Acta Portuguesa de Nutrição n.32 2023
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137400881938432